About Us

Program Background and Goals

The AIDS Education and Training Centers (AETC) Program of the Ryan White CARE Act currently supports a network of 11 regional centers (and more than 130 local performance sites) that conduct targeted, multi-disciplinary education and training programs for healthcare providers treating persons with HIV/AIDS. The AETCs serve all 50 States, the District of Columbia, the Virgin Islands, Puerto Rico, and the six U.S.-affiliated Pacific Jurisdictions. The mission of the AETCs is to improve the quality of life of patients living with HIV/AIDS through the provision of high quality professional education and training. The AETC Program is administered by the Health Resources and Services Administration (HRSA), HIV/AIDS Bureau.

For more information on HRSA, please visit HRSA's website. Included on the site are Biennial Progress Reports on the Ryan White HIV/AIDS Program, and the AETC Fact Sheet.

The North Carolina AIDS Training and Education Center is a Partner of the SE AETC Network.

David Wohl, MD - Program DirectorDW at Fall HIV Update

Clinical Associate Professor
Institute for Global Health and Infectious Diseases
UNC Chapel Hill

David Alain Wohl, MD is an Associate Professor of Medicine in the Institute for Global Health and Infectious Diseases at the University of North Carolina (UNC). He is Site Leader of the UNC AIDS Clinical Trials Unit at Chapel Hill and Co-Directs HIV Services for the North Carolina Department of Correction. In 2011, Dr. Wohl also became Director of the North Carolina AIDS Training and Education Center (NCATEC).

Dr. Wohl’s research interests fall into two major areas: the metabolic complications of HIV and its therapies and the nexus between incarceration and the HIV epidemic. He has chaired several related AIDS Clinical Trials Group (ACTG) studies and receives NIH funding for his corrections related research.

Dr. Wohl serves as a member of the Department of Health and Human Services (DHHS) HIV treatment guidelines panel and the National Institutes of Health (NIH) Behavioral and Social Consequences of HIV study review section. In addition to his research and administrative activities, Dr. Wohl maintains a large HIV continuity clinic at UNC and sees patients at the NC state prison.

Michele Bailey - Program Manager

Phone: (919) 843-8604
Fax: (919) 966-8536

Ms. Bailey has over 25 years of experience working in HIV and public health-related research, including stints at RTI and the American Social Health Association. She has operated HIV and vaccine call centers for the Centers for Disease Control and Prevention and developed UNC’s Health on Wheels Program, including designing the clinic space for the program’s mobile unit. At UNC’s Center for Infectious Diseases she coordinated the mobile unit program and the BRIGHT (Bridges to Good Health and Treatment) program before working with NCATEC.

Megan Katsaounis - Program Administrator

Phone: (919) 843-1510
Fax: (919) 966-8536

Becky White, MD, MPH

Assistant Professor of Medicine School of Medicine
Co-Director of HIV Services North Carolina Department of Correction

Dr. White is an HIV health service researcher and a practicing infectious disease physician involved in treatment and prevention of HIV/STDs in incarcerated persons and African-Americans. Dr. White uses her "real world" clinical experience to inform her research. Her research focuses on the dynamic interface between public health and medicine. She was one of the leading physician's who described the association between the release of HIV-infected prisoners and the subsequent deleterious effect (increase) on their viral loads. This connection continues to have significant HIV-transmission and health outcome implications for at-risk populations in the community as well as released prisoners. Furthermore, along with others, she conducted the first randomized controlled trial of directly observed antiretroviral therapy vs. self-administered antiretroviral therapy in a state prison system.

She also has participated in the implementation of the first ever HIV-opt out screening in the North Carolina state prison system. She is now expanding her research focus on the HIV at risk community and her research interests span from HIV screening/testing to access and adherence to highly active antiretroviral therapy in underserved populations. Her clinical interests include treatment of HIV infection and syphilis. She invites anyone interested in joining her research team to contact her.

Amanda H. Corbett, PharmD, BCPS, FCCP, CPP

Clinical Associate Professor, Eshelman School of Pharmacy and School of Medicine
Global Pharmacology Coordinator, Institute for Global Health and Infectious Diseases
UNC Chapel Hill

Dr. Corbett received a B.S. in Chemistry at the University of North Carolina in 1994 and a Doctor of Pharmacy degree from Campbell University in 1999. Subsequently, she completed a Pharmacy Practice Residency at Wake Forest University Baptist Medical Center and ID Specialty Residency (1 year) and HIV Pharmacology Fellowship at UNC (2 years).  At completion of her training in 2003, she joined the faculty at UNC Eshleman School of Pharmacy where responsibilities include teaching (didactic and experiential) clinical practice (UNC ambulatory care Infectious Diseases clinic), and clinical translational research.  She is a board certified pharmacotherapy specialist and is a fellow of the American College of Clinical Pharmacy.

She has an interest and focus in HIV pharmacology as well as Integrative Medicine. Dr. Corbett is pursuing training in various practices including nutrition, herbal pharmacology, and mind-body practices in order to enhance her teaching, clinical practice and scholarship. In addition, she is a certified yoga teacher and Reiki master.